Organo-ID
Balçova
About Organo-ID
Organo-ID provides preclinical models for metabolic liver disease and rare diseases such as citrullinemia and pyruvate decarboxylase. Additionally, they provide PDCOs that can test tumor response to treatments for individual patients and report on their results, which increases the chances of oncologists treating patients in a more personalized way.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $200.0K
- Funding stage: Seed
- Last round: Convertible Note (Jul 2022)
- Website: organo-id.com
- Phone: +90 532-447-46-37
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/organo-id-198808 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.